June 23 Quick Takes: Illumina selects first biotechs for U.K. accelerator; plus updates from the NASDAQ IPO queue, and venture rounds for Surrozen, Tara

Illumina launches U.K. accelerator campus
Illumina Inc. (NASDAQ:ILMN) selected three companies to join the first cohort of its new Cambridge, U.K.-based accelerator, and four genomics start-ups for the eleventh funding cycle at its San Francisco Bay Area campus. The Illumina Accelerator provides access to seed investment, its sequencing systems and reagents, as well as lab space, business guidance and genomics expertise.

Trio prepare for IPOs, plus secondary listing for Amryt
Three companies set terms on Friday for their public debuts on NASDAQ while London-based Amryt Pharma plc (LSE:AMYT; ISE:AYP) proposed to list and raise follow-on money on the exchange...